A practitioner asks: “An article [on the Internet] discusses the potential of fenbendazole, a common antiparasitic drug used in veterinary medicine, as a treatment for cancer. Fenbendazole (FBZ) has gained attention due to anecdotal reports suggesting it may have anticancer properties. FBZ may also enhance the efficacy of traditional cancer treatments like chemotherapy and radiation. FBZ though has no clinical literature as an anti-cancer treatment. How likely is it that FBZ could be a safe and effective anti-cancer treatment given that there are no treatment protocols, dosage, or side effect knowledge?”

As your question, in fact, makes clear, this substance is not ready for prime time. The interest in this agent was ramped up prematurely by cancer victim testimony that was taken out of context and done in ignorance by those involved, not appreciating their progress was due to simultaneous administration of established chemotherapeutics and not this experimental substance. We cannot pass judgment on this as it is human business as to whether there is a future utility of this chemical. We have made clear heretofore we are not, generally, at all in favor of pharmaceutical agents or the approach of chemotherapy for cancer management, except for the fortuitous availability of drugs with antiviral potency which are safe enough for widespread use but being ignored or covered up through mind control manipulation. We do not see this substance being in the same league.